• Home
  • Neoadjuvant therapy for HER2-positive early-stage breast cancer: the future is almost here.

Neoadjuvant therapy for HER2-positive early-stage breast cancer: the future is almost here.

Author List
Rugo HS
Publication
Oncology (Williston Park, N.Y.)
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1161417
Publication Year
2012
PubMed ID
22393793
Publication Title
Rugo HS. Neoadjuvant therapy for HER2-positive early-stage breast cancer: the future is almost here. Oncology (Williston Park). 2012 Jan; 26(1):26, 28-9.